Patents by Inventor OluFunmi Lily Johnson

OluFunmi Lily Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for sustained release of human growth hormone
    Publication number: 20030211153
    Abstract: A pharmaceutical composition for the sustained release of human growth hormone from a polymer matrix is disclosed. The pharmaceutical composition comprises a biocompatible polymer, particles of metal cation-complexed human growth hormone wherein said particles are dispersed within the biocompatible polymer and an aqueous injection vehicle.
    Type: Application
    Filed: October 29, 2002
    Publication date: November 13, 2003
    Inventors: Olufunmi Lily Johnson, Medha M. Ganmukhi, Howard Bernstein, Henry Auer, M. Amin Khan
  • Device for the sustained release of aggregation-stabilized, biologically active agent
    Publication number: 20030133979
    Abstract: A device for the sustained release in vivo of a water soluble, biologically active agent wherein the agent is susceptible to aggregation comprising a drug delivery device and aggregation-stabilized, biologically active agent wherein the aggregation-stabilized agent is disposed within the drug delivery device.
    Type: Application
    Filed: October 22, 2002
    Publication date: July 17, 2003
    Applicant: Alkermes Controlled Therapeutics, Inc.
    Inventors: Paul A. Burke, Stephen E. Zale, Mark A. Tracy, OluFunmi Lily Johnson, Howard Bernstein, M. Amin Khan, Avram Brickner, Henry E. Auer
  • Device for the sustained release of aggregation-stabilized, biologically active agent
    Patent number: 6514533
    Abstract: A device for the sustained release in vivo of a water soluble, biologically active agent wherein the agent is susceptible to aggregation comprising a drug delivery device and aggregation-stabilized, biologically active agent wherein the aggregation-stabilized agent is disposed within the drug delivery device.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: February 4, 2003
    Assignee: Alkermas Controlled Therapeutics, Inc.
    Inventors: Paul A. Burke, Stephen E. Zale, Mark A. Tracy, OluFunmi Lily Johnson, Howard Bernstein, M. Amin Khan, Henry E. Auer
  • Composition for sustained release of human growth hormone
    Patent number: 6500448
    Abstract: A pharmaceutical composition for the sustained release of human growth hormone from a polymer matrix is disclosed. The pharmaceutical composition comprises a biocompatible polymer, particles of metal cation-complexed human growth hormone wherein said particles are dispersed within the biocompatible polymer and an aqueous injection vehicle.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: December 31, 2002
    Assignee: Alkermes Controlled Therapeutics, Inc.
    Inventors: OluFunmi Lily Johnson, Medha M. Ganmukhi, Howard Bernstein, Henry Auer, M. Amin Khan
  • Composition for sustained release of human growth hormone
    Patent number: 6051259
    Abstract: The method of the invention for producing a composition for the sustained release of biologically active hGH includes dissolving a biocompatible polymer in a polymer solvent to form a polymer solution, dispersing particles of biologically active, metal cation-stabilized hGH in the polymer solution, and then solidifying the polymer to form a polymeric matrix containing a dispersion of said hGH particles.
    Type: Grant
    Filed: February 19, 1999
    Date of Patent: April 18, 2000
    Assignee: Alkermes Controlled Therapeutics, Inc.
    Inventors: OluFunmi Lily Johnson, Medha M. Ganmukhi, Howard Bernstein, Henry Auer, M. Amin Khan
  • Composition for sustained release of human growth hormone
    Patent number: 5891478
    Abstract: The method of the invention for producing a composition for the sustained release of biologically active hGH includes dissolving a biocompatible polymer in a polymer solvent to form a polymer solution, dispersing particles of biologically active, metal cation-stabilized hGH in the polymer solution, and then solidifying the polymer to form a polymeric matrix containing a dispersion of said hGH particles.
    Type: Grant
    Filed: March 2, 1998
    Date of Patent: April 6, 1999
    Assignee: Alkermes Controlled Therapeutics, Inc.
    Inventors: OluFunmi Lily Johnson, Medha M. Ganmukhi, Howard Bernstein, Henry Auer, M. Amin Khan
  • Composition for sustained release of human growth hormone
    Patent number: 5667808
    Abstract: The method of using the sustained release composition of the present invention comprises providing a therapeutically effective blood level of biologically active, non-aggregated human growth hormone in a subject for a sustained period by administering to the subject a dose of said sustained release composition.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 16, 1997
    Assignee: Alkermes, Inc.
    Inventors: OluFunmi Lily Johnson, Medha M. Ganmukhi, Howard Bernstein, Henry Auer, M. Amin Khan
  • Composition for sustained release of human growth hormone
    Patent number: 5654010
    Abstract: A composition, and methods of forming and using said composition, for the sustained release of biologically active, stabilized human growth hormone (hGH). The sustained release composition of this invention comprises a polymeric matrix of a biocompatible polymer and particles of biologically active, stabilized hGH, wherein said particles are dispersed within the biocompatible polymer. The method of the invention for producing a composition for the sustained release of biologically active hGH, includes dissolving a biocompatible polymer in a polymer solvent to form a polymer solution, dispersing particles of biologically active, stabilized hGH in the polymer solution, and then solidifying the polymer to form a polymeric matrix containing a dispersion of said hGH particles. The method for using a composition of the invention is a method for providing a therapeutically effective blood level of biologically active, non-aggregated hGH in a subject for a sustained period.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 5, 1997
    Assignee: Alkermes, Inc.
    Inventors: OluFunmi Lily Johnson, Medha M. Ganmukhi, Howard Bernstein, Henry Auer, M. Amin Khan